Preclinical Services for HIV Therapeutics

The National Institutes of Health has issued an award notice for solicitation 75N93019R00021 to support preclinical services for HIV therapeutics. This award establishes a competitive multiple-award, Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a seven-year ordering period effective from October 15, 2020, through October 14, 2027. Work will be performed in Iowa City, IA, under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AJ12 for General Science and Technology R&D Services; General Science and Technology; Applied Research.

Task orders issued under this contract will primarily utilize cost-reimbursement or term/completion structures to accommodate the evolving and science-driven nature of the requirements. While fixed-price task orders may be used where feasible, the government identified that the absence of precise specifications and the dynamic nature of the research results make fixed-price arrangements generally disadvantageous. The contractor is eligible to compete for task orders under Task Area E. Robert Corno serves as the primary point of contact for this award, which was published on October 20, 2020.